pubmed-article:11668468 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C1510483 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C0672250 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C1513183 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C0084785 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
pubmed-article:11668468 | lifeskim:mentions | umls-concept:C0677862 | lld:lifeskim |
pubmed-article:11668468 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:11668468 | pubmed:dateCreated | 2001-10-22 | lld:pubmed |
pubmed-article:11668468 | pubmed:abstractText | The distinction of a primary lung carcinoma from a metastatic lesion is important, because the treatment and prognosis differ for patients with these malignancies. Such a distinction can be difficult because of overlapping cytologic features. It has been shown that antibodies to thyroid transcription factor 1 (TTF-1) and PE-10 are fairly specific markers for primary lung tumors in histologic specimens. TTF-1 regulates the expression of surfactant protein production, and PE-10 is a monoclonal antibody against components of human surfactant proteins. The combination of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) immunoprofiling has been helpful in the identification of the primary site of origin of lung tumors. | lld:pubmed |
pubmed-article:11668468 | pubmed:language | eng | lld:pubmed |
pubmed-article:11668468 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11668468 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11668468 | pubmed:month | Oct | lld:pubmed |
pubmed-article:11668468 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:11668468 | pubmed:author | pubmed-author:CohenJ MJM | lld:pubmed |
pubmed-article:11668468 | pubmed:author | pubmed-author:GoswamiSS | lld:pubmed |
pubmed-article:11668468 | pubmed:author | pubmed-author:ZakowskiM FMF | lld:pubmed |
pubmed-article:11668468 | pubmed:author | pubmed-author:SUNF CFC | lld:pubmed |
pubmed-article:11668468 | pubmed:author | pubmed-author:ChhiengD CDC | lld:pubmed |
pubmed-article:11668468 | pubmed:author | pubmed-author:CangiarellaJ... | lld:pubmed |
pubmed-article:11668468 | pubmed:copyrightInfo | Copyright 2001 American Cancer Society. | lld:pubmed |
pubmed-article:11668468 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11668468 | pubmed:day | 25 | lld:pubmed |
pubmed-article:11668468 | pubmed:volume | 93 | lld:pubmed |
pubmed-article:11668468 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11668468 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11668468 | pubmed:pagination | 330-6 | lld:pubmed |
pubmed-article:11668468 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:meshHeading | pubmed-meshheading:11668468... | lld:pubmed |
pubmed-article:11668468 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11668468 | pubmed:articleTitle | Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. | lld:pubmed |
pubmed-article:11668468 | pubmed:affiliation | Department of Pathology, University of Alabama at Birmingham, 35249-6823, USA. dchhieng@path.uab.edu | lld:pubmed |
pubmed-article:11668468 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11668468 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11668468 | lld:pubmed |